惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

H
Hackread – Cybersecurity News, Data Breaches, AI and More
C
Check Point Blog
Hacker News: Ask HN
Hacker News: Ask HN
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
WordPress大学
WordPress大学
P
Proofpoint News Feed
V
Visual Studio Blog
C
Cyber Attacks, Cyber Crime and Cyber Security
N
Netflix TechBlog - Medium
C
CXSECURITY Database RSS Feed - CXSecurity.com
博客园 - 聂微东
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
博客园 - 叶小钗
Cisco Talos Blog
Cisco Talos Blog
S
Schneier on Security
T
Threat Research - Cisco Blogs
腾讯CDC
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
The Hacker News
The Hacker News
Google DeepMind News
Google DeepMind News
Microsoft Security Blog
Microsoft Security Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
GbyAI
GbyAI
N
News | PayPal Newsroom
L
LINUX DO - 最新话题
酷 壳 – CoolShell
酷 壳 – CoolShell
P
Palo Alto Networks Blog
T
Tenable Blog
S
Secure Thoughts
T
Threatpost
V2EX - 技术
V2EX - 技术
大猫的无限游戏
大猫的无限游戏
Martin Fowler
Martin Fowler
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Vercel News
Vercel News
罗磊的独立博客
P
Privacy & Cybersecurity Law Blog
Engineering at Meta
Engineering at Meta
小众软件
小众软件
Google DeepMind News
Google DeepMind News
N
News and Events Feed by Topic
Y
Y Combinator Blog
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
C
Cybersecurity and Infrastructure Security Agency CISA
P
Proofpoint News Feed
L
Lohrmann on Cybersecurity
P
Privacy International News Feed
H
Heimdal Security Blog
量子位
B
Blog

FourWeekMBA

Musk vs Altman: The $90B Fight That Will Define AI’s Future Why DeepMind’s $1.1B Bet Signals the End of Human-Trained AI The AI Orchestrator's Leverage Points AI & The Harness Theory Why AI Companies Are Selling Fiction as Partnership Strategy Google’s $40B Anthropic Bet Reveals AI Infrastructure Wars Anthropic’s Agent Economy Signals End of Human-Mediated Commerce Claude OS: The AI Strategy Skill That Turns Claude Into Your Analyst Agent Harness OS: Build AI-Augmented Strategic Operations 🔥 AI & The Harness Theory 🔥 The Harnessing Players Map of AI 🔥 The Business Engineer’s Claude Code OS 🔥 Skills as the Architecture of the Personal OS Google's $40B Anthropic Bet Exposes Big Tech's AI Desperation Google's $40B Anthropic Bet Signals Platform Wars 2.0 20 Mental Models For AI Business Google's TPU Gambit: Why Hardware Will Crown the AI King LinkedIn Business Model: How LinkedIn Makes Money (2026) Netflix Organizational Structure: The Culture of Freedom (2026) Amazon Pricing Strategy: How Amazon Uses Price to Win Amazon Supply Chain: The Logistics Empire (2026) Apple Supply Chain: How Apple Built the World’s Best Supply Chain Tesla Supply Chain: Vertical Integration Strategy (2026) Anthropic Business Model: How Anthropic Makes Money (2026) OpenAI Business Model: How OpenAI Makes Money (2026) Meta (Facebook) Organizational Structure 2026 Google's Agentic TPUs Signal the Death of Traditional SaaS Google's $40B Anthropic Bet Signals The End of AI Independence The OpenAI–Anthropic Convergent Bets Google’s $40B Anthropic Bet Signals the End of Open AI Innovation The Business Engineer's Claude Code OS Pentagon’s $54B Drone Budget Reveals the New Defense Economy Google's $40B Anthropic Bet Signals the End of Open AI Markets Apple’s CEO Transition Reveals the Platform Monopoly Trap Why Worldcoin’s Fake Partnership Signals AI’s Trust Crisis Google's TPU Play Signals the End of GPU Monopoly Artisan’s “Stop Hiring Humans” Stunt Reveals AI’s Marketing Problem GaaS vs SaaS: Why AI Agents Kill Per-Seat Pricing Defensible Moats in AI: What Actually Protects an AI Company The Software Collapse: When Code Becomes a Liability Apple's Subscription Empire Signals The End of Product Innovation Google’s TPU Gambit: The Hardware War for AI Agents AI & The Importance of System Thinking Why Prego’s Kitchen Surveillance Signals Audio’s Next Battleground Apple’s Subscription Pivot Reveals Platform Monopoly Endgame Tesla’s $25B Bet Signals Manufacturing’s AI Revolution Physical AI Market Map: Where Real-World AI Creates Value From SaaS to AgaaS: How AI Agents Are Killing Per-Seat Pricing Prego’s Kitchen Surveillance Reveals Big Food’s Data Desperation Tim Cook’s Subscription Trap Is Killing Apple’s Innovation DNA The Chinese AI Economy OpenAI-OpenClaw Deal & the War for Personal Agents The Shape of the Agentic Interface The RLVR-to-Agentic Use Case Map The Agentic Architecture Race The SaaS Destruction Map The State of Agentic AI The Turning Point The Post-SaaS Expansion Map Five Predictions for the Agentic Economy The Five Scaling Phases of AI The Great Interface Inversion The Agent-Native API The AI Value Chain of Work Capacity-Priority Mismatch Matrix Salesforce & The Agentic Cannibalization NVIDIA & The State of AI The System of Action The Strategic Bet Matrix AI Agents & The New Payment Infrastructure Why World Chose Tinder as Its Humanness Beachhead Uber's Assetmaxxing Era: The Robotaxi Reckoning AI Business Brief: OpenAI’s 12-Month Window and the Great Consolidation — April 20, 2026 Content Marketing Strategy vs Meta/Facebook Growth Strategy: Key Differences & When to Use Each [2026] Netflix Business Model vs Disney Business Model: Key Differences & When to Use Each [2026] Facebook/Meta Business Model vs Amazon Business Model: Key Differences & When to Use Each [2026] DTC Model vs Wholesale Model: Key Differences & When to Use Each [2026] Marketplace Model vs Platform Model: Key Differences & When to Use Each [2026] Value Chain Analysis vs Supply Chain: Key Differences & When to Use Each [2026] Apple Business Model vs Samsung Business Model: Key Differences & When to Use Each [2026] Uber Business Model vs Lyft Business Model: Key Differences & When to Use Each [2026] Cost Leadership vs Differentiation Strategy: Key Differences & When to Use Each [2026] Freemium vs Subscription Model: Key Differences & When to Use Each [2026] Porter’s Five Forces vs SWOT Analysis: Key Differences & When to Use Each [2026] Porter’s Five Forces vs PESTEL Analysis: Key Differences & When to Use Each [2026] Salesforce & The Agentic Cannibalization: Interactive Analysis Micron & The AI Memory Bottleneck: Constraint Map The AI Reasoning Growth Loop: Memory & Flywheel Framework - FourWeekMBA The Inference Economy: Interactive Framework - FourWeekMBA Amazon in the AI Era: From E-Commerce Giant to AI Infrastructure Power - FourWeekMBA Google in the AI Era: How the Business Model Is Evolving - FourWeekMBA AI Strategy Cheat Sheets: Top 10 Frameworks in One Page - FourWeekMBA AI Landscape Explorer: Every Company Analyzed - FourWeekMBA AI Strategy Learning Paths: Four Guided Journeys - FourWeekMBA Which AI Framework Do You Need? Interactive Quiz - FourWeekMBA NVIDIA’s Industrial AI Thesis: Five Structural Trends - FourWeekMBA The Business Engineer Database: 663 AI & Business Strategy Analyses - FourWeekMBA The State of Business AI — March 2026 Executive Report - FourWeekMBA The State of Agentic AI: Interactive Report - FourWeekMBA The SaaS Destruction Map: $2T Revenue Repriced - FourWeekMBA
What Companies Does Johnson & Johnson Own in 2026?
Gennaro Cuof · 2026-05-19 · via FourWeekMBA

Johnson & Johnson is a multinational corporation with a core focus on consumer-packaged goods (CPGs), pharmaceutical products, and medical devices.

With a headquarters in New Brunswick, New Jersey, Johnson & Johnson is one of only two American companies with a higher credit rating than the United States government.

Johnson & Johnson was founded in 1886 by brothers Edward Mead and James Wood Johnson.

Some of the company’s earliest products included medical guides and sterile surgical supplies with a company logo that closely resembles the one used today.

The Johnson & Johnson family of companies is comprised of more than 250 subsidiaries with countless brands concentrated in consumer healthcare.

Some of these are described in the following sections.

Tylenol

Tylenol is a consumer drug brand for pain, fever, allergies, colds, and influenza. The brand name itself was derived from the chemical nomenclature of the paracetamol compound on which it is based. 

Tylenol was first released in 1955 by pharmaceutical manufacturer McNeil Laboratories as an elixir for children. This was the first aspirin-free product to be released in the USA at the time.

The brand was acquired by Johnson & Johnson in 1959 and Tylenol was approved for sale without a prescription soon after.

Aveeno

Aveeno is a skin and hair care brand that was established in 1945 by brothers Sidney and Albert Musher.

Aveeno is known for the active ingredient colloidal oats which has anti-inflammatory properties that can treat eczema, psoriasis, and sunburn, among other skin conditions.

After Mayo Clinic dermatologists recognized the work of the Musher brothers in oat-based skincare, the brand was born.

This culture of research remains today as Johnson & Johnson continues to study Aveeno’s role in the microbial diversity of healthy skin.

Listerine

Listerine is a mouthwash brand that was named after Joseph Lister, a pioneer of antiseptic surgery at the Glasgow Royal Infirmary.

Inspired by Lister’s work, American Dr. Joseph Lawrence created an alcohol-based concoction containing menthol, methyl salicylate, eucalyptol, and thymol – a proprietary compound whose composition remains a trade secret.

Johnson & Johnson acquired the Listerine brand in 2006 as part of the deal that saw it purchase Pfizer’s consumer healthcare division for $16.6 billion.

Band-Aid

Band-Aid is an adhesive bandage product and one of the most recognized brands in the world.

The word “band-aid” has entered common language in many countries as a catch-all term for adhesive bandages, but it’s also used colloquially to describe a solution to a quick or superficial solution that does not address the root cause of a problem.

The first bandage was invented by Johnson & Johnson employee Earle Dickson in 1920 in response to his wife who frequently burned or cut herself in the kitchen.

Band-Aid products were initially handmade and not that successful before mass production and sterilization increased sales in the late 1930s.

Nicorette

Nicorette is a nicotine replacement therapy (NRT) brand whose first product was a chewing gum developed and released in Sweden in 1971.

In subsequent years, different NRT products have been released. These include oral sprays, tablets, inhalators, and lozenges.

Nicorette is still manufactured in Sweden by Johnson & Johnson subsidiary McNeil Consumer Healthcare. 

History of Johnson & Johnson

Johnson & Johnson is a medical device, pharmaceutical, and CPG multinational that was founded by Robert, James, and Edward Johnson in 1886. Today, the company has around 250 subsidiaries and operates in more than 60 countries with sales in 2022 of $94.9 billion.

Early years

Robert Wood Johnson first developed an interest in healthcare during the American Civil War. Johnson understood that most of the 720,000 soldier deaths were caused by infection and disease that were themselves the result of poor hygiene standards in the operating room.

Johnson worked as a pharmaceutical apprentice for a time, and then in 1873, founded Seabury & Johnson with George Seabury. The company became known for its medicated mustard plasters which delivered pain relief to the skin via a sealed, adhesive bandage. 

Johnson & Johnson is founded

In 1876, Johnson attended the World’s Fair in Philadelphia which also happened to be the largest assembly of medical professionals to date. There, he heard Dr. Joseph Lister speak about a radical new procedure known as antiseptic surgery and became convinced that it was the future of medicine.

Johnson parted ways with Seabury and started Johnson & Johnson with brothers Edward Mead and James Wood Johnson in 1886. The company was the first to mass-produce sterile surgical supplies, but it also produced household items and an instructional guide on how to perform sterile surgeries with its products.

Entitled The Modern Methods of Antiseptic Wound Treatment, the guide was distributed to over 85,000 doctors and pharmacists in 1888 and significantly advanced the healthcare industry as well as bolstering Johnson & Johnson’s reputation. 

Early twentieth century

The company increased production to meet the demand for surgical products during World War I and also invented an early surgical mask in response to the 1918 influenza pandemic. 

In 1920, inventor Earle Dickson combined Johnson & Johnson adhesive tape and gauze to create the now-iconic Band-Aid adhesive bandage. The product went on sale in 1921, which also coincided with the release of Johnson’s Baby Soap. 

Johnson & Johnson goes public

Johnson & Johnson became a publicly traded company in 1944. It was also around this time that Robert Wood Johnson II (who had taken over as president in 1932) developed the company’s defining document known as “Our Credo”.

The 1950s and 60s were marked by a period of expansion. In 1956, the company established a presence in the Philippines and one in India the following year. It also acquired McNeil Laboratories (1959), Janssen Pharmaceuticals (1961), and healthcare technology company Codman & Shurtleff in 1965.

Over this period, the company was at the forefront of medical innovation. Some of its contributions include a vaccine to prevent hemolytic disease in babies, a tube test for anemia detection, an arterial graft for coronary bypass surgery, and, in 1987, the first disposable contact lenses.

Further acquisitions

After the fall of the USSR, Johnson & Johnson aggressively entered Europe and acquired some of its most recognizable brands. These include Motrin, Aveeno, Neutrogena, and Clean & Clear.

The company then acquired Pfizer’s consumer healthcare arm in 2006 for $16.6 billion and added brands such as Neosporin, Bengay, and Listerine to its portfolio. That same year, it released a protease inhibitor treatment for HIV sufferers.

Acquisitions continued over the 2010s – some of them significant. Johnson & Johnson acquired Abbott Medical Optics for $4.325 billion in 2017 to shore up its human vision division. This was followed by the gargantuan $30 billion acquisition of biotech company Actelion, with the company spinning off Actelion’s R&D unit into a separate company.

More recent purchases include Momenta Pharmaceuticals in 2020, and the $16.6 billion takeover of medical device technology company Abiomed Inc in November 2022. CEO Joaquin Duato noted that “We are excited to officially welcome the talented Abiomed team to Johnson & Johnson. Their patient-first philosophy aligns with Our Credo and Our Purpose to change the future of health for humanity.

Key takeaways

  • Johnson & Johnson is a multinational corporation with a core focus on CPGs, pharmaceutical products, and medical devices.
  • The Johnson & Johnson brand Tylenol was the first paracetamol-based painkiller in the United States. Aveeno is an oat-based skincare brand with considerable scientific backing and research.
  • Some other Johnson & Johnson brands include Nicorette, Listerine, and Band-Aid, one of the most recognizable brands in the world.
  • In 1876, Johnson attended the World’s Fair in Philadelphia and heard Dr. Joseph Lister speak about a radical new procedure known as antiseptic surgery. Convinced that it was the future of medicine, Johnson founded Johnson & Johnson with brothers Edward Mead and James Wood Johnson in 1886.
  • Johnson & Johnson became a publicly traded company in 1944. It was also around this time that Robert Wood Johnson II (who had taken over as president in 1932) developed the company’s defining document known as “Our Credo”.
  • The 1950s and 60s were marked by a period of expansion. The company established a presence in the Philippines in 1956 and one in India in 1957. It also acquired McNeil Laboratories (1959), Janssen Pharmaceuticals (1961), and healthcare technology company Codman & Shurtleff in 1965. Subsequent decades strengthened the company’s position in consumer healthcare and also yielded several important innovations.

More Resources: